Quinone-Containing Conjugates for Novel Therapeutic and Diagnostic Applications

Publication ID: 24-11857638_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Quinone-Containing Conjugates for Novel Therapeutic and Diagnostic Applications,” Published Technical Disclosure No. 24-11857638_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857638_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,638.

Summary of the Inventive Concept

The present disclosure relates to the application of quinone-containing conjugates to new therapeutic and diagnostic areas, including neurological disorders, skin conditions, and cardiovascular diseases, enabling targeted treatment and detection.

Background and Problem Solved

The original patent disclosed quinone-containing conjugates for the treatment of proliferative disorders. However, these conjugates were limited to a specific application. The present inventive concept addresses the need for more versatile and adaptable conjugates that can be applied to a broader range of therapeutic and diagnostic areas.

Detailed Description of the Inventive Concept

The quinone-containing conjugates of formula (I) are adapted for use in novel therapeutic and diagnostic applications. The conjugates selectively target and destroy cells associated with neurological disorders, skin conditions, and cardiovascular diseases. The conjugates can be linked to detection agents for biomarker detection or used as therapeutic agents for targeted treatment. The conjugates' versatility is demonstrated by their ability to be administered in various forms, including compositions and kits.

Novelty and Inventive Step

The new claims introduce novel therapeutic and diagnostic applications for quinone-containing conjugates, which were not contemplated in the original patent. The inventive concept lies in the recognition of the conjugates' potential in these new areas and the adaptation of the conjugates to address specific challenges in these fields.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept include variations in the linker, payload, and cell-binding moiety to optimize the conjugates for specific applications. Additionally, the conjugates could be used in combination with other therapeutic agents or detection methods to enhance their effectiveness.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and diagnostic industries, with applications in neurological disorders, skin conditions, and cardiovascular diseases. The market for these applications is substantial, and the quinone-containing conjugates offer a promising solution for targeted treatment and detection.

CPC Classifications

SectionClassGroup
A A61 A61K47/6889
A A61 A61K31/122
A A61 A61K47/6891
A A61 A61K49/0039
A A61 A61K49/0043
A A61 A61K49/0052
C C07 C07D417/12
C C07 C07K16/30
G G01 G01N33/582

Original Patent Information

Patent NumberUS 11,857,638
TitleQuinone-containing conjugates
Assignee(s)Promega Corporation